Grace Halsey

ADA 2020. An investigational once-weekly insulin proved comparable in safety and efficacy to traditional once-daily insulin glargine in findings presented at the ADA 80th Annual Virtual Scientific Sessions.

ADA 2020. Dapagliflozin reduced new onset type 2 diabetes in patients with heart failure with reduced ejection fraction, according to a study released today at the ADA 80th Virtual Scientific Sessions.

ADA2020: Empagliflozin significantly, durably delays need for insulin and for large dose increases, in patients with type 2 diabetes and cardiovascular disease, finds study presented at ADA 80th Scientific Sessions.

ADA 2020: A new automatic insulin delivery system improves glycemic control in young people with type 1 diabetes, according to research presented at the American Diabetes Association Virtual Scientific Sessions.

The New York Times asked 511 epidemiologists when they might resume hair cuts, shaking hands, air travel, bus rides, and 15 other "normal" activities suspended during COVID-19 social distancing.

The American Diabetes Association kicks off its Virtual 80th Scientific Sessions on Friday, June 12, 2020. Here is our guide to top sessions.

"Asymptomatic coronavirus spread is rare." World Health Organization explains the miscommunication.

Get a snapshot of the diabetes data most important to primary care from the National Diabetes Statistics Report, 2020.

THEMIS trial results showed a statistically significant reduction in risk of MACE with ticagrelor plus aspirin vs aspirin alone in patients with CAD at high risk of first heart attack or stroke.

Experts in infectious disease rate a wide range of summer activities as low, medium, or high COVID-19 risk. When your patients ask, you'll be ready.

Early forecasts of COVID-19 burden on US hospitals based on data from China may have underestimated need at peak infection, a new study suggests.

Diabetes patients are at risk for severe SARS-CoV2 infection. Here, find new evidence-based guidance from an international panel, on how to manage these patients.

Study authors project that, if COVID-19 returns, a 1-week delay in social distancing could require up to 17 more days to once again slow the spread.

FDA has asked 5 US companies to voluntarily recall lots of metformin extended release after detection of NDMA contamination.

The structural changes created in bariatric surgery increase the release of gut hormones that communicate satiety to the brain.

An independent association between asthma and risk of cardiovascular disease remained even after adjusting for other CVD risk factors, authors report.

Patients trust their doctors but are reluctant to visit any medical location, even for needed care, a new survey shows. More, here,on shifts in attitudes and behavior.

Hydroxychloroquine and chloroquine were associated with increased risk of death among more than 96 000 patients hospitalized with COVID-19.

US adults expect to see a COVID-19 vaccine this year and most (72%) are likely to get it. Here are demographics on this, vaccine clinical trials, and compassionate use.

The COVID-19 pandemic continues to be fertile ground for odd and often dangerous myths about transmission, prevention, and treatment. We found 5 new ones.

University of Oxford researchers will recruit more than 10 000 participants and evaluate groups of young and elderly to evaluate immune response across the lifespan.

As COVID-19 stay-at-home restrictions lift, primary care practices should be strategic about when and how to open. The AMA provides a step-by-step guide.

States with high concentrations of vulnerable populations, eg, older, sicker, but also poorer with basic needs unmet, face challenges as the COVID-19 lock-down lifts.

Analyses showed that times to first revascularization events were significantly reduced by icosapent ethyl vs placebo across subtypes of intervention.

The metabolic pathology that underlies obesity must be addressed through medication or bariatric surgery or significant weight loss will be transient.

A majority of group practices are seeing patients in person again as questions on safety, PPE supplies, and patient fears continue.

The most recent responses from primary care physicians to the hard questions about patients and practice (Survey May 6-12, 2020).

The orally administered antiviral agent will enter phase II trials to be conducted at multiple US locations, including 3 Mayo Clinic sites.

A blog post on COVID-19 transmission by a US biology professor at UMass Dartmouth went viral this week. Find out what your patients are reading and test yourself, too.

Antiviral remdesivir donated by Gilead Sciences is being shipped to areas in the US hardest hit by COVID-19.